SCHEMBL13622170

SCHEMBL13622170

COC(=O)c1cccc(CBr)c1-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
LMNA P02545 3/20 0.51
TSHR P16473 2/20 0.45
MAPT P10636 3/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
MAPK10 P53779 2/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
PTK2B Q14289 1/20 0.44
NCOA1 Q15788 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
NCOA3 Q9Y6Q9 1/20 0.44
HIF1A Q16665 1/20 0.44
CFTR P13569 1/20 0.44
HSD17B10 Q99714 1/20 0.44
SLC6A3 Q01959 4/20 0.43
ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6782256 0.82 HNF4A (0.49) ALDH1A1LMNATSHRMAPTALOX15
SCHEMBL104703 0.82 ALDH1A1 (0.67) ALDH1A1LMNATSHRMAPTKMT2A
SCHEMBL30945155 0.82 ALDH1A1 (0.67) ALDH1A1LMNATSHRMAPTKMT2A
SCHEMBL28289664 0.80 FABP4 (0.55) ALDH1A1LMNATSHRMAPTKMT2A
SCHEMBL29094948 0.79 FABP4 (0.54) ALDH1A1LMNATSHRMAPTKMT2A
SCHEMBL8384755 0.78 ALDH1A1 (0.50) ALDH1A1LMNATSHRMAPTKMT2A
SCHEMBL5839700 0.78 ALDH1A1 (0.53) ALDH1A1LMNATSHRMAPTKMT2A
SCHEMBL1760164 0.78 ALDH1A1 (0.53) ALDH1A1LMNATSHRMAPTKMT2A
SCHEMBL20377207 0.78 ALDH1A1 (0.53) ALDH1A1LMNATSHRMAPTKMT2A
SCHEMBL1424324 0.78 ALDH1A1 (0.53) ALDH1A1LMNATSHRMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622612-B2 Tricyclic derivatives and their use CHEMTECH RESEARCH INCORPORATION (KR) 2009-11-24 US disclosed
US-7622612-B2 Tricyclic derivatives and their use CHEMTECH RESEARCH INCORPORATION (KR) 2009-11-24 US disclosed
US-20070021427-A1 Novel tricyclic derivatives and their use CHEMTECH RESEARCH INCORPORATION (KR) 2007-01-25 US disclosed
US-20070021427-A1 Novel tricyclic derivatives and their use CHEMTECH RESEARCH INCORPORATION (KR) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021427-A1 Novel tricyclic derivatives and their use NFATC1, IL2, CCL2 ALDH1A1 2078/4885LMNA 4574/4885TSHR 4563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.